Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation

Cell Reports
Miguel Angel BurguillosTomas Deierborg

Abstract

Inflammatory response induced by microglia plays a critical role in the demise of neuronal populations in neuroinflammatory diseases. Although the role of toll-like receptor 4 (TLR4) in microglia's inflammatory response is fully acknowledged, little is known about endogenous ligands that trigger TLR4 activation. Here, we report that galectin-3 (Gal3) released by microglia acts as an endogenous paracrine TLR4 ligand. Gal3-TLR4 interaction was further confirmed in a murine neuroinflammatory model (intranigral lipopolysaccharide [LPS] injection) and in human stroke subjects. Depletion of Gal3 exerted neuroprotective and anti-inflammatory effects following global brain ischemia and in the neuroinflammatory LPS model. These results suggest that Gal3-dependent-TLR4 activation could contribute to sustained microglia activation, prolonging the inflammatory response in the brain.

References

Apr 1, 1992·Journal of Neuroscience Research·V BocchiniH Kettenmann
Jan 1, 1996·Journal of Biochemistry·K Kasai, J Hirabayashi
May 5, 1998·Developmental Dynamics : an Official Publication of the American Association of Anatomists·C ColnotF Poirier
Mar 29, 2002·Chembiochem : a European Journal of Chemical Biology·Pernilla SörmeUlf J Nilsson
Apr 22, 2005·Apoptosis : an International Journal on Programmed Cell Death·S NakaharaA Raz
Jan 25, 2008·The Journal of Biological Chemistry·Sean R StowellRichard D Cummings
Feb 28, 2008·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Tomas DeierborgGustav Mattiasson
Jan 8, 2010·Neurobiology of Disease·Christina DoverhagKarin Sävman
Apr 10, 2010·Nature Reviews. Drug Discovery·Elizabeth J HennessyLuke A J O'Neill
Apr 21, 2010·Journal of Neurochemistry·Madison M BuchananHang Yin
Aug 24, 2010·The Journal of Biological Chemistry·Françoise Debierre-GrockiegoRalph T Schwarz
Sep 3, 2010·The Journal of Biological Chemistry·Emma SalomonssonHakon Leffler
Sep 30, 2010·Biochemistry·Emma SalomonssonHakon Leffler
Nov 11, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Ana R InácioTomas Deierborg
Nov 23, 2010·Nature Reviews. Immunology·Grace Y Chen, Gabriel Nuñez
Aug 13, 2011·Cell Death and Differentiation·J L VeneroB Joseph
Oct 26, 2011·Nature Reviews. Immunology·Kaoru Saijo, Christopher K Glass
May 3, 2012·The Journal of Biological Chemistry·Adriana LepurHakon Leffler
Jun 29, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Kate Lykke LambertsenBente Finsen
Jul 28, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Mélanie Lalancette-HébertJasna Kriz
Dec 29, 2012·Methods : a Companion to Methods in Enzymology·Susanne A I SeidelStefan Duhr
Nov 13, 2014·Acta Neuropathologica Communications·Antonio Boza-SerranoTomas Deierborg

❮ Previous
Next ❯

Citations

Sep 10, 2015·FEBS Letters·Ada G BlidnerGabriel A Rabinovich
Mar 6, 2016·Clinica Chimica Acta; International Journal of Clinical Chemistry·Yong-Feng ShenLi Jiang
Jan 16, 2016·Oxidative Medicine and Cellular Longevity·Stefano MeniniGiuseppe Pugliese
Oct 27, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Guoqing CaiWei Zou
Jun 13, 2015·Progress in Neurobiology·Rafael Franco, Diana Fernández-Suárez
Aug 20, 2016·Journal of the Neurological Sciences·Xin-Jiang YanWei-Min Dai
Sep 7, 2016·Brain, Behavior, and Immunity·Wyston C PierreGregory A Lodygensky
Sep 10, 2016·PloS One·Patrik Maximilian BauerUlrica Englund-Johansson
Feb 28, 2017·Scientific Reports·Youichirou HigashiMotoaki Saito
May 6, 2017·BioMed Research International·Jingdun XieBingtian Bi
Dec 23, 2015·International Journal of Molecular Sciences·Silke NeumannAndrew N Clarkson
Jan 27, 2018·International Journal of Molecular Sciences·Salvatore SciacchitanoAlberto Ricci
Feb 8, 2018·Brain Sciences·Hirofumi Nishikawa, Hidenori Suzuki
May 14, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Koji NomuraGuy C Brown
Sep 6, 2017·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P AroraM Cushman
May 15, 2015·Journal of Neuroinflammation·Oscar ManouchehrianLinnéa Taylor
May 16, 2018·Endocrine Connections·Eva Olga MelinMagnus Hillman
Mar 21, 2019·European Journal of Immunology·Bojan StojanovicMiodrag L Lukic
Jun 6, 2018·Frontiers in Molecular Neuroscience·Jian Jing Siew, Yijuang Chern
Oct 11, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yihui ChenGuangxun Meng
Oct 20, 2019·Cellular and Molecular Life Sciences : CMLS·Charlotte G H M de JongWia Baron
Apr 5, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yu-Wen HungSheau-Ling Lee
Apr 13, 2020·Journal of Neurochemistry·David Hans AllendorfGuy Charles Brown
Apr 19, 2020·Current Opinion in Neurology·Francisca BarakeAlfonso González

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Caspases in Metabolic Diseases

Caspases, the family of cysteine proteases are involved in programmed cell death, but their role in metabolic diseases, inflammation and immunity has been of interested. Discover the latest research on caspases in metabolic diseases here.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.